15 September 2022 News

Apira Strengthen Executive Team

Apira strengthens executive team

Healthcare consultancy Apira has strengthened its executive team with the appointment of Charles Skinner as Non-Exec Chairman and Dr Robin Woolfson as Medical Director and Non-Exec Director.

Charles is an experienced business executive, and was previously CEO at Restore PLC, a document management solution provider which, during his 10-year tenure, grew to one of the most successful constituents of the Alternative Investment Market (AIM).

Robin is a Consultant Nephrologist, originally appointed to Middlesex (UCLH) and Whittington Hospitals in 1997. He has been based at the Royal Free Hospital since 2005 where he was Medical Director (2017-19). Prior to that, he was Divisional Director for Transplantation and Specialist Services (2009-17) and Clinical Director for Renal and Hepatology Services (2006-9). In these roles, Robin has had significant managerial responsibilities with a focus on clinical service transformation. He has been the Secondary Care Doctor on the Governing Body of Buckinghamshire Clinical Commissioning Group since 2016.

Mark Jones, MD for Apira said “We are delighted to welcome Charles and Robin to the Apira team, as they are widely respected business and clinical leaders and understand the benefits that digital tools and technologies can enable in improving the quality, safety and efficiency of healthcare delivery.”


Charles Skinner
Non Exec Chairman

Dr Robin Woolfson
Medical Director and Non-Exec Director